CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Mexico

• NCT05327114

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

  i Can Oncology Center, Monterrey · Clinical Research Institute S.C., Tlalnepantla

  Registry updated 2026-11-03

• NCT06859099

  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 4840001, Tlalnepantla

  Registry updated 2026-10-27

• NCT06290141

  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 4840002, Chihuahua City · Investigational Site Number : 4840001, Tlalnepantla

  Registry updated 2026-10-19

• NCT07032662

  Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2 · Immunovant Sciences GmbH

  Site Number - 2603, Colonia del Valle · Site Number - 2600, Culiacán · Site Number - 2602, Tlalpan · Site Number - 2601, Veracruz

  Registry updated 2026-09-30

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error